It was reported that the patient experienced loss of stimulation and an increase of rigidity, dysarthria, and tremors.Reprogramming was performed, but the patient did not have the same coverage.The patients device settings were reviewed and when the system was turned off, the increased symptoms disappeared.The patients impedances are within normal range, but the patient increases their medication to compensate for the stimulation issues.Database analysis was performed and no device anomalies were found.An x-ray was also taken and the physician found no issues.The patient then underwent a revision procedure to explant and replace the implantable pulse generator (ipg).The patient is stable and doing well postoperatively.
|
With all available information, boston scientific concludes through laboratory analysis that the event loss of stimulation and the increase of rigidity, dysarthria, and tremors were not able to be confirmed as the ipg passed all tests performed.Additionally, the event of the increase of rigidity, dysarthria, and tremors are known inherent risks with the use of deep brain stimulation as documented in the instructions for use (ifu).The returned db-1200 ipg was analyzed, passed all tests performed, and exhibited normal device characteristics.A product labeling review identified that the device was used per the instructions for use (ifu) / product label.The ifu states that the following is a list of known risks with the use of deep brain stimulation: embolism, including air embolism and pulmonary embolism, hemorrhagic or ischemic stroke, immediate or delayed, which could result in temporary or permanent neurologic deficits such as muscle weakness, paralysis or aphasia peripheral nerves, brain (including pneumocephalus), or pleura (including pneumothorax), loss of adequate stimulation, mentation impairment such as attention or cognitive deficits, memory disturbances, or confusion, motor problems such as paresis, weakness, incoordination, restlessness, muscle spasms, postural and gait disorders, tremor, dystonia, or dyskinesias, and falls or injuries resulting from these problem, musculoskeletal stiffness, neuroleptic malignant syndrome or acute akinesia can occur very rarely, overstimulation or undesirable sensations, such as paresthesia, transient or persistent, pain, headache or discomfort, transient or persistent, including symptoms due to neurostimulation.
|
It was reported that the patient experienced an increase of rigidity, dysarthria, and loss of stimulation.Reprogramming was performed, but the patient did not have the same coverage.The patient's device settings were reviewed and when the system was turned off, the increased symptoms disappeared.The patient's device exhibits good impedances, but the patient increases their medication to compensate for the inadequate stimulation.An x-ray was taken and the physician found no issues.The patient then underwent a revision procedure to explant and replace the implantable pulse generator (ipg).The patient is stable and doing well postoperatively.
|